Last Updated: September 28 2022

Echinacea purpurea is an herb commonly used either in response to or daily for prevention of the common cold. It outperforms placebo unreliably and the amount of benefit derived is similarly unreliable.

Echinacea is most often used for

What is Echinacea?

The term "echinacea" refers to a genera of plants, and a few species in this family including purpurea and angustifolia are desired due to their alkylamide content (seen as the active ingredients). It's often taken as a tincture, but dry capsules are also common.

What are Echinacea's benefits?

Overall, echinacea appears to be somewhat effective for fighting off upper respiratory tract infections (mostly studied for the common cold), and when taken consistently as a prophylactic, it has support from research. It has also been studied for its potential ability to accelerate the rate of recovery in sickness, but the current evidence for that highly ambiguous. There are trials suggesting remarkable recovery rates, and there are trials suggesting no benefits whatsoever. Overall, it doesn't look very potent. Limited research suggests that it can increase the levels of a variety of immune cells, but more research is needed to be confident in this.

What are Echinacea's drawbacks and downsides?

Echinacea hasn't demonstrated notably, greater adverse events in trials than placebo, however, as with herbal extracts in general, there may be a risk for drug interactions, particularly for those who take multiple medications.

What else is Echinacea known as?
Note that Echinacea is also known as:
  • Brauneria purpurea
  • Echinacea intermedia
  • Rudbeckia purpurea
  • Purple coneflower herb
  • Coneflower
  • Red sunflower
Dosage information

For dehydrated powders (including encapsulated echinacea) the species of purpuera tends to be used and oral doses are taken upwards of 300mg thrice a day (900mg daily) and 500mg thrice daily (1,500mg daily).

Tinctures of an ethanolic extract of the aerial parts (leaves and stems) appears to be used in the concentration of 2.5mL thrice a day or up to 10mL daily.

There is no much evidence as to whether these are the optimal doses, and studies seem to be very hetereogeneous in their benefits due to lack of standardization.

Join our supplement information course

Examine Database: Echinacea
What works and what doesn't?

Unlock the full potential of Examine

Get started

Don't miss out on the latest research

2.^Wu L, Rowe EW, Jeftinija K, Jeftinija S, Rizshsky L, Nikolau BJ, McKay J, Kohut M, Wurtele ESEchinacea-induced cytosolic Ca2+ elevation in HEK293BMC Complement Altern Med.(2010 Nov 23)
4.^Najm W, Lie DDietary supplements commonly used for preventionPrim Care.(2008 Dec)
6.^Bright-Gbebry M, Makambi KH, Rohan JP, Llanos AA, Rosenberg L, Palmer JR, Adams-Campbell LLUse of multivitamins, folic acid and herbal supplements among breast cancer survivors: the black women's health studyBMC Complement Altern Med.(2011 Apr 15)
7.^Engdal S, Klepp O, Nilsen OGIdentification and exploration of herb-drug combinations used by cancer patientsIntegr Cancer Ther.(2009 Mar)
8.^Walsh NP, Gleeson M, Pyne DB, Nieman DC, Dhabhar FS, Shephard RJ, Oliver SJ, Bermon S, Kajeniene APosition statement. Part two: Maintaining immune healthExerc Immunol Rev.(2011)
9.^Senchina DS, Shah NB, Doty DM, Sanderson CR, Hallam JEHerbal supplements and athlete immune function--what's proven, disproven, and unprovenExerc Immunol Rev.(2009)
10.^Ritchie MR, Gertsch J, Klein P, Schoop REffects of Echinaforce® treatment on ex vivo-stimulated blood cellsPhytomedicine.(2011 Jul 15)
11.^Thomsen MO, Fretté XC, Christensen KB, Christensen LP, Grevsen KSeasonal variations in the concentrations of lipophilic compounds and phenolic acids in the roots of Echinacea purpurea and Echinacea pallidaJ Agric Food Chem.(2012 Dec 12)
12.^Hohmann J, Rédei D, Forgo P, Szabó P, Freund TF, Haller J, Bojnik E, Benyhe SAlkamides and a neolignan from Echinacea purpurea roots and the interaction of alkamides with G-protein-coupled cannabinoid receptorsPhytochemistry.(2011 Oct)
15.^Bauer R, Remiger PTLC and HPLC Analysis of Alkamides in Echinacea Drugs1,2Planta Med.(1989 Aug)
17.^Chen Y, Fu T, Tao T, Yang J, Chang Y, Wang M, Kim L, Qu L, Cassady J, Scalzo R, Wang XMacrophage activating effects of new alkamides from the roots of Echinacea speciesJ Nat Prod.(2005 May)
19.^Benson JM, Pokorny AJ, Rhule A, Wenner CA, Kandhi V, Cech NB, Shepherd DMEchinacea purpurea extracts modulate murine dendritic cell fate and functionFood Chem Toxicol.(2010 May)
20.^Liu Y, Zhang S, Zhang F, Hu RAdjuvant activity of Chinese herbal polysaccharides in inactivated veterinary rabies vaccinesInt J Biol Macromol.(2012 Apr 1)
22.^Ragupathi G, Yeung KS, Leung PC, Lee M, Lau CB, Vickers A, Hood C, Deng G, Cheung NK, Cassileth B, Livingston PEvaluation of widely consumed botanicals as immunological adjuvantsVaccine.(2008 Sep 2)
24.^Chicca A, Pellati F, Adinolfi B, Matthias A, Massarelli I, Benvenuti S, Martinotti E, Bianucci AM, Bone K, Lehmann R, Nieri PCytotoxic activity of polyacetylenes and polyenes isolated from roots of Echinacea pallidaBr J Pharmacol.(2008 Mar)
25.^Binns SE, Livesey JF, Arnason JT, Baum BRPhytochemical variation in echinacea from roots and flowerheads of wild and cultivated populationsJ Agric Food Chem.(2002 Jun 19)
30.^Kim HO, Durance TD, Scaman CH, Kitts DDRetention of alkamides in dried Echinacea purpureaJ Agric Food Chem.(2000 Sep)
31.^Kim HO, Durance TD, Scaman CH, Kitts DDRetention of caffeic acid derivatives in dried Echinacea purpureaJ Agric Food Chem.(2000 Sep)
33.^Livesey J, Awang DV, Arnason JT, Letchamo W, Barrett M, Pennyroyal GEffect of temperature on stability of marker constituents in Echinacea purpurea root formulationsPhytomedicine.(1999 Nov)
35.^Patterson MFMicrobiology of pressure-treated foodsJ Appl Microbiol.(2005)
39.^Woelkart K, Marth E, Suter A, Schoop R, Raggam RB, Koidl C, Kleinhappl B, Bauer RBioavailability and pharmacokinetics of Echinacea purpurea preparations and their interaction with the immune systemInt J Clin Pharmacol Ther.(2006 Sep)
41.^Shah SA, Sander S, White CM, Rinaldi M, Coleman CIEvaluation of echinacea for the prevention and treatment of the common cold: a meta-analysisLancet Infect Dis.(2007 Jul)
42.^Matthias A, Blanchfield JT, Penman KG, Toth I, Lang CS, De Voss JJ, Lehmann RPPermeability studies of alkylamides and caffeic acid conjugates from echinacea using a Caco-2 cell monolayer modelJ Clin Pharm Ther.(2004 Feb)
43.^Jager H, Meinel L, Dietz B, Lapke C, Bauer R, Merkle HP, Heilmann JTransport of alkamides from Echinacea species through Caco-2 monolayersPlanta Med.(2002 May)
44.^Matthias A, Penman KG, Matovic NJ, Bone KM, De Voss JJ, Lehmann RPBioavailability of Echinacea constituents: Caco-2 monolayers and pharmacokinetics of the alkylamides and caffeic acid conjugatesMolecules.(2005 Oct 30)
45.^Matthias A, Gillam EM, Penman KG, Matovic NJ, Bone KM, De Voss JJ, Lehmann RPCytochrome P450 enzyme-mediated degradation of Echinacea alkylamides in human liver microsomesChem Biol Interact.(2005 Jun 30)
46.^Woelkart K, Koidl C, Grisold A, Gangemi JD, Turner RB, Marth E, Bauer RBioavailability and pharmacokinetics of alkamides from the roots of Echinacea angustifolia in humansJ Clin Pharmacol.(2005 Jun)
47.^Matthias A, Addison RS, Penman KG, Dickinson RG, Bone KM, Lehmann RPEchinacea alkamide disposition and pharmacokinetics in humans after tablet ingestionLife Sci.(2005 Sep 2)
48.^Goey AK, Rosing H, Meijerman I, Sparidans RW, Schellens JH, Beijnen JHThe bioanalysis of the major Echinacea purpurea constituents dodeca-2E,4E,8Z,10E/Z-tetraenoic acid isobutylamides in human plasma using LC-MS/MSJ Chromatogr B Analyt Technol Biomed Life Sci.(2012 Aug 1)
49.^Gorski JC, Huang SM, Pinto A, Hamman MA, Hilligoss JK, Zaheer NA, Desai M, Miller M, Hall SDThe effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivoClin Pharmacol Ther.(2004 Jan)
50.^Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Carrier J, Khan IA, Edwards DJ, Shah AIn vivo assessment of botanical supplementation on human cytochrome P450 phenotypes: Citrus aurantium, Echinacea purpurea, milk thistle, and saw palmettoClin Pharmacol Ther.(2004 Nov)
51.^Gurley BJ, Swain A, Hubbard MA, Williams DK, Barone G, Hartsfield F, Tong Y, Carrier DJ, Cheboyina S, Battu SKClinical assessment of CYP2D6-mediated herb-drug interactions in humans: effects of milk thistle, black cohosh, goldenseal, kava kava, St. John's wort, and EchinaceaMol Nutr Food Res.(2008 Jul)
52.^Moltó J, Valle M, Miranda C, Cedeño S, Negredo E, Barbanoj MJ, Clotet BHerb-drug interaction between Echinacea purpurea and darunavir-ritonavir in HIV-infected patientsAntimicrob Agents Chemother.(2011 Jan)
53.^Penzak SR, Robertson SM, Hunt JD, Chairez C, Malati CY, Alfaro RM, Stevenson JM, Kovacs JAEchinacea purpurea significantly induces cytochrome P450 3A activity but does not alter lopinavir-ritonavir exposure in healthy subjectsPharmacotherapy.(2010 Aug)
54.^Abdul MI, Jiang X, Williams KM, Day RO, Roufogalis BD, Liauw WS, Xu H, Matthias A, Lehmann RP, McLachlan AJPharmacokinetic and pharmacodynamic interactions of echinacea and policosanol with warfarin in healthy subjectsBr J Clin Pharmacol.(2010 May)
58.^Woelkart K, Xu W, Pei Y, Makriyannis A, Picone RP, Bauer RThe endocannabinoid system as a target for alkamides from Echinacea angustifolia rootsPlanta Med.(2005 Aug)
59.^Chicca A, Raduner S, Pellati F, Strompen T, Altmann KH, Schoop R, Gertsch JSynergistic immunomopharmacological effects of N-alkylamides in Echinacea purpurea herbal extractsInt Immunopharmacol.(2009 Jul)
60.^Raduner S, Majewska A, Chen JZ, Xie XQ, Hamon J, Faller B, Altmann KH, Gertsch JAlkylamides from Echinacea are a new class of cannabinomimetics. Cannabinoid type 2 receptor-dependent and -independent immunomodulatory effectsJ Biol Chem.(2006 May 19)
61.^Woelkart K, Bauer RThe role of alkamides as an active principle of echinaceaPlanta Med.(2007 Jun)
62.^Haller J, Bakos N, Szirmay M, Ledent C, Freund TFThe effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxietyEur J Neurosci.(2002 Oct)
64.^Piomelli D, Tarzia G, Duranti A, Tontini A, Mor M, Compton TR, Dasse O, Monaghan EP, Parrott JA, Putman DPharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597)CNS Drug Rev.(2006 Spring)
65.^Haller J, Freund TF, Pelczer KG, Füredi J, Krecsak L, Zámbori JThe anxiolytic potential and psychotropic side effects of an echinacea preparation in laboratory animals and healthy volunteersPhytother Res.(2013 Jan)
66.^Shah SA, Schlesselman L, Cios D, Lipeika J, Patel AA, Kluger J, White CMEffects of echinacea on electrocardiographic and blood pressure measurementsAm J Health Syst Pharm.(2007 Aug 1)
68.^Goel V, Chang C, Slama JV, Barton R, Bauer R, Gahler R, Basu TKAlkylamides of Echinacea purpurea stimulate alveolar macrophage function in normal ratsInt Immunopharmacol.(2002 Feb)
69.^Sullivan AM, Laba JG, Moore JA, Lee TDEchinacea-induced macrophage activationImmunopharmacol Immunotoxicol.(2008)
70.^Stevenson LM, Matthias A, Banbury L, Penman KG, Bone KM, Leach DL, Lehmann RPModulation of macrophage immune responses by EchinaceaMolecules.(2005 Oct 31)
72.^Rossol M, Heine H, Meusch U, Quandt D, Klein C, Sweet MJ, Hauschildt SLPS-induced cytokine production in human monocytes and macrophagesCrit Rev Immunol.(2011)
73.^Senchina DS, Strauch JH, Hoffmann GB, Shah NB, Laflen BK, Dumke BL, Dao CT, Dias AS, Perera MAPhytochemical and immunomodulatory properties of an Echinacea laevigata (Asteraceae) tinctureJ Altern Complement Med.(2011 Apr)
74.^Kapai NA, Anisimova NY, Kiselevskii MV, Sitdikova SM, Slavetskaya MBSelective cytokine-inducing effects of low dose EchinaceaBull Exp Biol Med.(2011 Apr)
75.^Skopińska-Rózewska E, Sokolnicka I, Siwicki AK, Stankiewicz W, Dabrowski MP, Buchwald W, Krajewska-Patan A, Mielcarek S, Mścisz A, Furmanowa MDose-dependent in vivo effect of Rhodiola and Echinacea on the mitogen-induced lymphocyte proliferation in micePol J Vet Sci.(2011)
76.^Zhai Z, Liu Y, Wu L, Senchina DS, Wurtele ES, Murphy PA, Kohut ML, Cunnick JEEnhancement of innate and adaptive immune functions by multiple Echinacea speciesJ Med Food.(2007 Sep)
77.^Sasagawa M, Cech NB, Gray DE, Elmer GW, Wenner CAEchinacea alkylamides inhibit interleukin-2 production by Jurkat T cellsInt Immunopharmacol.(2006 Jul)
78.^Mishima S, Saito K, Maruyama H, Inoue M, Yamashita T, Ishida T, Gu YAntioxidant and immuno-enhancing effects of Echinacea purpureaBiol Pharm Bull.(2004 Jul)
79.^Morazzoni P, Cristoni A, Di Pierro F, Avanzini C, Ravarino D, Stornello S, Zucca M, Musso TIn vitro and in vivo immune stimulating effects of a new standardized Echinacea angustifolia root extract (Polinacea)Fitoterapia.(2005 Jul)
81.^Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka KImmunobiology of dendritic cellsAnnu Rev Immunol.(2000)
82.^Wang CY, Chiao MT, Yen PJ, Huang WC, Hou CC, Chien SC, Yeh KC, Yang WC, Shyur LF, Yang NSModulatory effects of Echinacea purpurea extracts on human dendritic cells: a cell- and gene-based studyGenomics.(2006 Dec)
83.^Wang CY, Staniforth V, Chiao MT, Hou CC, Wu HM, Yeh KC, Chen CH, Hwang PI, Wen TN, Shyur LF, Yang NSGenomics and proteomics of immune modulatory effects of a butanol fraction of echinacea purpurea in human dendritic cellsBMC Genomics.(2008 Oct 13)
84.^Dong GC, Chuang PH, Chang KC, Jan PS, Hwang PI, Wu HB, Yi M, Zhou HX, Chen HMBlocking effect of an immuno-suppressive agent, cynarin, on CD28 of T-cell receptorPharm Res.(2009 Feb)
86.^Yu D, Yuan Y, Jiang L, Tai Y, Yang X, Hu F, Xie ZAnti-inflammatory effects of essential oil in Echinacea purpurea LPak J Pharm Sci.(2013 Mar)
88.^Woelkart K, Linde K, Bauer REchinacea for preventing and treating the common coldPlanta Med.(2008 May)
89.^Schoop R, Klein P, Suter A, Johnston SLEchinacea in the prevention of induced rhinovirus colds: a meta-analysisClin Ther.(2006 Feb)
90.^Linde K, Barrett B, Wölkart K, Bauer R, Melchart DEchinacea for preventing and treating the common coldCochrane Database Syst Rev.(2006 Jan 25)
91.^Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJAssessing the quality of reports of randomized clinical trials: is blinding necessaryControl Clin Trials.(1996 Feb)
92.^Taylor JA, Weber W, Standish L, Quinn H, Goesling J, McGann M, Calabrese CEfficacy and safety of echinacea in treating upper respiratory tract infections in children: a randomized controlled trialJAMA.(2003 Dec 3)
93.^Sperber SJ, Shah LP, Gilbert RD, Ritchey TW, Monto ASEchinacea purpurea for prevention of experimental rhinovirus coldsClin Infect Dis.(2004 May 15)
94.^Turner RB, Bauer R, Woelkart K, Hulsey TC, Gangemi JDAn evaluation of Echinacea angustifolia in experimental rhinovirus infectionsN Engl J Med.(2005 Jul 28)
98.^Schulten B, Bulitta M, Ballering-Brühl B, Köster U, Schäfer MEfficacy of Echinacea purpurea in patients with a common cold. A placebo-controlled, randomised, double-blind clinical trialArzneimittelforschung.(2001)
100.^Barrett BP, Brown RL, Locken K, Maberry R, Bobula JA, D'Alessio DTreatment of the common cold with unrefined echinacea. A randomized, double-blind, placebo-controlled trialAnn Intern Med.(2002 Dec 17)
103.^Gleeson M, Lancaster GI, Bishop NCNutritional strategies to minimise exercise-induced immunosuppression in athletesCan J Appl Physiol.(2001)
104.^Gleeson M, Nieman DC, Pedersen BKExercise, nutrition and immune functionJ Sports Sci.(2004 Jan)
106.^Hall H, Fahlman MM, Engels HJEchinacea purpurea and mucosal immunityInt J Sports Med.(2007 Sep)
108.^Whitehead MT, Martin TD, Scheett TP, Webster MJRunning economy and maximal oxygen consumption after 4 weeks of oral Echinacea supplementationJ Strength Cond Res.(2012 Jul)
109.^Whitehead MT, Martin TD, Scheett TP, Webster MJThe effect of 4 wk of oral echinacea supplementation on serum erythropoietin and indices of erythropoietic statusInt J Sport Nutr Exerc Metab.(2007 Aug)
110.^Szołomicki J, Samochowiec L, Wójcicki J, Droździk MThe influence of active components of Eleutherococcus senticosus on cellular defence and physical fitness in manPhytother Res.(2000 Feb)
111.^Di Carlo G, Pacilio M, Capasso R, Di Carlo REffect on prolactin secretion of Echinacea purpurea, hypericum perforatum and Eleutherococcus senticosusPhytomedicine.(2005 Sep)
112.^Dragland S, Senoo H, Wake K, Holte K, Blomhoff RSeveral culinary and medicinal herbs are important sources of dietary antioxidantsJ Nutr.(2003 May)
118.^Sharma M, Schoop R, Hudson JBThe efficacy of Echinacea in a 3-D tissue model of human airway epitheliumPhytother Res.(2010 Jun)
119.^Goel V, Chang C, Slama J, Barton R, Bauer R, Gahler R, Basu TEchinacea stimulates macrophage function in the lung and spleen of normal ratsJ Nutr Biochem.(2002 Aug)
120.^Fusco D, Liu X, Savage C, Taur Y, Xiao W, Kennelly E, Yuan J, Cassileth B, Salvatore M, Papanicolaou GAEchinacea purpurea aerial extract alters course of influenza infection in miceVaccine.(2010 May 21)
121.^Bodinet C, Mentel R, Wegner U, Lindequist U, Teuscher E, Freudenstein JEffect of oral application of an immunomodulating plant extract on Influenza virus type A infection in micePlanta Med.(2002 Oct)
122.^Uluışık D, Keskin EEffects of ginseng and echinacea on cytokine mRNA expression in ratsScientificWorldJournal.(2012)
123.^Yamada K, Hung P, Park TK, Park PJ, Lim BOA comparison of the immunostimulatory effects of the medicinal herbs Echinacea, Ashwagandha and BrahmiJ Ethnopharmacol.(2011 Sep 1)
125.^Posadzki P, Watson LK, Ernst EAdverse effects of herbal medicines: an overview of systematic reviewsClin Med.(2013 Feb)
127.^Askeroglu U, Alleyne B, Guyuron BPharmaceutical and herbal products that may contribute to dry eyesPlast Reconstr Surg.(2013 Jan)
128.^[No authors listedDon't take echinacea if you're allergic to ragweedConsum Rep.(2012 Feb)
129.^Mullins RJEchinacea-associated anaphylaxisMed J Aust.(1998 Feb 16)
130.^Mullins RJ, Heddle RAdverse reactions associated with echinacea: the Australian experienceAnn Allergy Asthma Immunol.(2002 Jan)